- TM Capital served as exclusive financial advisor to InNeuroCo, Inc. in its sale to Integer Holdings Corporation (NYSE:ITGR)
- Founded in 2014 and headquartered in Pembroke Pines, Florida, InNeuroCo is a leading founder-owned designer and contract manufacturer of ultra-precise, highly-engineered neurovascular catheters
- InNeuroCo’s primary products are single-use catheters principally used in interventional neurovascular procedures for the treatment of ischemic strokes and aneurysms
- Offering turnkey product design and development, supported by comprehensive domestic manufacturing capabilities, InNeuroCo serves as a mission-critical supply partner to the world’s preeminent medical device OEMs
- With approximately $1.4 billion in annual revenue, Integer is one of the largest medical device outsource manufacturers in the world, serving the cardiac, vascular, rhythm management and neuromodulation markets
Client Testimonial
"InNeuroCo’s founders have enjoyed a long-standing history of success with the TM healthcare team. When we began contemplating a transaction for InNeuroCo, TM was the obvious choice to serve as our advisor. Throughout this transaction, their knowledge of the neurovascular sector, valuable strategic insights and demonstrated expertise in contract medical manufacturing were critical to engineering a successful outcome for InNeuroCo. We appreciate TM Capital’s tireless dedication and thoughtful approach."- Marc Litzenberg, President & CEO, InNeuroCo
